XNYS
IQV
Market cap42bUSD
Oct 08, Last price
258.88USD
1D
0.30%
1Q
24.55%
Jan 2017
240.41%
IPO
510.71%
Name
IQVIA Holdings Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
IQVIA Holdings Inc. is a global leader empowering the life sciences sector with advanced analytics, innovative technology solutions, and comprehensive clinical research services. Operating across the Americas, Europe, Africa, and the Asia-Pacific regions, its capabilities are organized into three main divisions. Within its Technology & Analytics Solutions segment, IQVIA delivers cloud-based applications alongside essential implementation services. It also specializes in real-world solutions, enabling clients to generate and disseminate crucial evidence that informs healthcare decisions and ultimately enhances patient outcomes. This segment extends its expertise to strategic and implementation consulting, encompassing advanced analytics and commercial process outsourcing. Furthermore, it furnishes comprehensive market performance data, tracking pharmaceutical sales, prescribing trends, treatment efficacy, and promotional activities at a granular level – from country-wide views down to regional, zip code, and individual prescriber insights, across diverse channels like retail, hospital, and mail order. The Research & Development Solutions segment offers a broad spectrum of support for clinical trials, from initial strategic planning and design to meticulous project management and clinical monitoring, including innovative virtual trial capabilities. Complementing these, it provides an extensive array of laboratory services, such as central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment focuses on engaging healthcare providers and patients, alongside offering scientific strategy and medical affairs support. IQVIA's client base spans pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. Additionally, the firm maintains a strategic alliance with HealthCore, Inc. Founded in 1982, the company was initially known as Quintiles IMS Holdings, Inc., before rebranding as IQVIA Holdings Inc. in November 2017. Its corporate headquarters are situated in Durham, North Carolina.
Related entities
Subsidiaries (12)
EXCEL LIFE SCIENCES PRIVATE LIMITED
IQVIA INC.
IQVIA LTD.
IQVIA Solutions Belgium
159 TECHNOLOGY SOLUTIONS PRIVATE LIMITED
FORESIGHT IT SOLUTIONS AND CONSULTING INDIA PRIVATE LIMITED
IMS SOFTWARE SERVICES LTD.
IQVIA AG
IQVIA ANALYTICS SERVICES PRIVATE LIMITED
IQVIA CONSULTING AND INFORMATION SERVICES INDIA PRIVATE LIMITED
IQVIA RDS (INDIA) PRIVATE LIMITED
IQVIA RDS ITALY SRL
Key people
Chairman of the Board, Chief Executive Officer · since 2022
Bhavik Patel
President, Commercial Solutions · since 2024
Walter Staub
President - Research and Development Solutions · since 2023
Michael Fedock
Chief Financial Officer, Executive Vice President · since 2026
Eric Sherbet
Executive Vice President, General Counsel, Secretary · since 2018
Lead Independent Director · since 2018
Carol Burt
Independent Director · since 2019
Independent Director · since 2008
Independent Director · since 2016
James Fasano
Independent Director · since 2016
Independent Director · since 2017
Leslie Morris
Independent Director · since 2022
Independent Director · since 2016
Independent Director · since 2022
Legal address
C/O CORPORATION SERVICE COMPANY
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
2400 Ellis Road
Durham, NC 27703
US
Durham, NC 27703
US
Previous name
Quintiles IMS Holdings, Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||